Drug interactions
Meningococcal group b vaccine + Temozolomide
Severity: Moderate
Meningococcal group b vaccine and Temozolomide: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Temozolomide-related immunosuppression may reduce the antibody response to the non-live meningococcal B vaccine, leading to weaker or shorter protection.
What this interaction means in plain words
Meningococcal group b vaccine and Temozolomide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Chemotherapy-induced immunosuppression reduces vaccine immunogenicity.
What to do
Vaccinate before chemotherapy or during count recovery when possible, and do not delay vaccination in high-risk patients. Consider revaccination after immune recovery.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Meningococcal group b vaccine and Temozolomide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Temozolomide
Frequently asked questions
Can I take Meningococcal group b vaccine with Temozolomide?
MediHelp rates the interaction as moderate. Meningococcal group b vaccine and Temozolomide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Temozolomide-related immunosuppression may reduce the antibody response to the non-live meningococcal B vaccine, leading to weaker or shorter protection.
How serious is the interaction between Meningococcal group b vaccine and Temozolomide?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Vaccinate before chemotherapy or during count recovery when possible, and do not delay vaccination in high-risk patients. Consider revaccination after immune recovery.
What other medicines interact with Temozolomide?
MediHelp also lists interactions of Temozolomide with, for example, Adenovirus types 4 and 7 live, Belatacept, Deferiprone. The full list is on the Temozolomide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
